Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.

BACKGROUND: Patients with type 2 diabetes mellitus are at increased risk of cardiovascular disease, partly owing to dyslipidaemia, which can be amenable to fibrate therapy. We designed the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study to assess the effect of fenofibrate on c...

Full description

Bibliographic Details
Main Authors: Keech, A, Simes, R, Barter, P, Best, J, Scott, R, Taskinen, MR, Forder, P, Pillai, A, Davis, T, Glasziou, P, Drury, P, Kesäniemi, Y, Sullivan, D, Hunt, D, Colman, P, d'Emden, M, Whiting, M, Ehnholm, C, Laakso, M
Format: Journal article
Language:English
Published: 2005

Similar Items